Youngkyu Park

Chonnam National University — South Korea

Medicine · Health Sciences

45h-index15.2kcitations336works2.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pancreatic and Hepatic Oncology Research(126), Epigenetics and DNA Methylation(47), Cancer Cells and Metastasis(38), Gastric Cancer Management and Outcomes(38), Pancreatic function and diabetes(37)

Publications336 total

Supplementary Figure S1-S11 and Table S1 from Splicing Factor SRSF1 Promotes Pancreatitis and KRAS<sup>G12D</sup>-Mediated Pancreatic Cancer
2025Open Access
MYC-Driven Activation of USP39 Enhances SRSF1 Stability and Promotes PDAC Progression
2025Open Access
Supplementary Figure S6 from FGFR2 Abrogation Intercepts Pancreatic Ductal Adenocarcinoma Development
2025Open Access
Supplementary Figure S8 from FGFR2 Abrogation Intercepts Pancreatic Ductal Adenocarcinoma Development
2025Open Access
Supplementary Table S3 from FGFR2 Abrogation Intercepts Pancreatic Ductal Adenocarcinoma Development
2025Open Access
Supplementary Figure S7 from FGFR2 Abrogation Intercepts Pancreatic Ductal Adenocarcinoma Development
2025Open Access
Data from FGFR2 Abrogation Intercepts Pancreatic Ductal Adenocarcinoma Development
2025Open Access
Supplementary Table S1 from FGFR2 Abrogation Intercepts Pancreatic Ductal Adenocarcinoma Development
2025Open Access
Supplementary Figure S9 from FGFR2 Abrogation Intercepts Pancreatic Ductal Adenocarcinoma Development
2025Open Access
Supplementary Figure S3 from FGFR2 Abrogation Intercepts Pancreatic Ductal Adenocarcinoma Development
2025Open Access
Supplementary Figure S2 from FGFR2 Abrogation Intercepts Pancreatic Ductal Adenocarcinoma Development
2025Open Access
Supplementary Figure S5 from FGFR2 Abrogation Intercepts Pancreatic Ductal Adenocarcinoma Development
2025Open Access
Supplementary Figure S1 from FGFR2 Abrogation Intercepts Pancreatic Ductal Adenocarcinoma Development
2025Open Access
Supplementary Table S2 from FGFR2 Abrogation Intercepts Pancreatic Ductal Adenocarcinoma Development
2025Open Access
Supplementary Figure S4 from FGFR2 Abrogation Intercepts Pancreatic Ductal Adenocarcinoma Development
2025Open Access
FGFR2 Abrogation Intercepts Pancreatic Ductal Adenocarcinoma Development
Cancer Research·2025· 4 citedOpen Access
Clinicopathological Factors Affecting Stomach Preservation Following Laparoscopic Sentinel Node Navigation Surgery in Patients with Early Gastric Cancer: A Secondary Analysis of the Multicenter Randomized Phase III SENORITA Trial
Annals of Surgical Oncology·2025
Long-term outcomes of laparoscopic distal gastrectomy for locally advanced gastric cancer: An individual patient data meta-analysis of KLASS-02 and CLASS-01 randomized controlled trials
Chinese Journal of Cancer Research·2025Open Access
Dietary pro-oxidant therapy by a vitamin K precursor targets PI 3-kinase VPS34 function
Science·2024· 35 citedOpen Access
Ductal pancreatic cancer interception by FGFR2 abrogation
2024Open Access
page 1 of 17Next →

Frequent Co-authors

David A. Tuveson(18), Tobiloba E. Oni(7), Hervé Tiriac(7), Giulia Biffi(6), Ela Elyada(6), Chang‐Il Hwang(6), Hao Yuan(6), Evelyn T. Maizels(6), Mary Hunzicker-Dunn(6), J. Larry Jameson(6), Iok In Christine Chio(5), Lindsey A. Baker(5), Dannielle D. Engle(5), Kevin Wright(5), Daniel Öhlund(4), Mariano Ponz‐Sarvisé(4), Vincenzo Corbo(4), Kenneth H. Yu(4), Keith Rivera(4), Darryl Pappin(4)